Lsi Europe 25

Name	:	LSI Europe 25
Website	:	Visit Website
Blog	:	Visit Blog
Social Links	:

About Lsi Europe 25

We curate thousands of proprietary company presentations, industry panels, interviews and more insightful content featuring the leaders at the forefront of Medtech and Healthtech. The Maestro system is designed to assist surgeons in performing minimally invasive procedures with greater accuracy and control. Moon�s innovative technology aims to reduce the physical strain on surgeons, minimize patient recovery time, and improve overall surgical outcomes.

Perseverance: The Key to Long-Term Value Creation

Lsi Europe 2504 Mar, 2025Business

The medtech journey is rarely a straight line, and both panelists emphasized the importance of perseverance and patience. Makower reflected on the industry’s unique challenges: In medtech, success is about patience and perseverance. If you believe in your technology and have the data to back it up, stick with it. Real value is created over time.

Unlocking Medtech Investment: Insights from Visionary Leaders

Lsi Europe 2524 Feb, 2025Business

Navigating the medtech landscape requires a blend of innovation, resilience, and strategic partnership. At LSI Europe ‘24, industry stalwarts Antoine Papiernik, Chairman and Managing Partner of Sofinnova Partners, and Josh Makower, Co-Founder of Stanford Byers Center for Biodesign and Venture Partner at Sofinnova Partners, took center stage to shed light on medtech investment, sharing experiences that spanned decades of transformative industry growth.

The State of Maternal Healthcare Disparities

Lsi Europe 2522 Feb, 2025Business

The statistics surrounding maternal health are sobering. Andrew Pieprzyk, Vice President of Strategic Development at Hologic, shared, “Less than half of women in the EU were screened for high blood pressure last year and only 24% for diabetes, 20% for cancer, and 8% for STIs.

Technology Transfer in Medtech: The Path to Successful Investments

Lsi Europe 2511 Feb, 2025Business

Technology transfer is a critical bridge between groundbreaking academic research and real-world medtech solutions. Yet, ensuring a smooth transition from lab to market comes with its own set of challenges. At LSI Europe ’24, a panel of seasoned investors and industry leaders gathered to discuss the key factors that drive successful technology transfer while avoiding common pitfalls.

Navigating U.S. Market Access as an International Medtech Company

Lsi Europe 2505 Feb, 2025Business

Expanding into the U.S. market presents both tremendous opportunities and formidable challenges for international medtech companies. At LSI Europe ’24, a panel of industry experts, including venture capitalists, regulatory consultants, and executives from medtech startups, discussed the key considerations and strategies for achieving successful U.S. market access. From navigating regulatory pathways to commercial execution, the discussion provided insights into how international companies can position themselves for growth and eventual exit in the world’s largest healthcare market.

Innovations Bridging the Gap in Maternal Healthcare

Lsi Europe 2528 Jan, 2025Business

One of the core themes of the panel was the potential of innovative technologies to mitigate maternal healthcare disparities. The speakers emphasized that solutions must be both preventative and empowering, giving women the tools to actively engage in their healthcare journey.

Medical Device Companies to Watch: Moon Surgical Wins FDA Clearance for Commercial Version of Maestr

Lsi Europe 2525 Jan, 2025Business

Moon Surgical has announced that its Maestro System has received FDA clearance for commercial use. This milestone marks a significant leap forward in Moon’s ascent in robot-assisted laparoscopic surgery, promising to enhance the precision and efficiency of various surgical procedures.

From Tech Titan to Healthcare Visionary

Lsi Europe 2524 Jan, 2025Business

Cohen's career trajectory is a testament to the power of cross-industry pollination. With nearly three decades in the tech sector, including pivotal roles at IBM and Cisco, he brings a unique perspective to the medtech landscape. Reflecting on his experience, Cohen stated, "It is much easier to build a business if you're satisfying demand versus creating demand." This insight shaped his approach to healthcare innovation, emphasizing the importance of understanding market needs.

Investment Thesis and Strategic Focus

Lsi Europe 2503 Dec, 2024Business

Michael Ryan from Boston Scientific explained, "We consider ourselves a strategic investor. For us to invest in a company, three things need to be true: it needs to be an investment-grade asset with a great team and technology, it must be available at terms that provide the potential for financial return, and it needs to operate in a space that is a strategic fit for one of our six operating units.

The Role of Strategic Investors for Medtech Startups

Lsi Europe 2527 Nov, 2024Business

Navigating strategic partnerships and M&As is a critical aspect of growth for startups in the medtech market. Building the right relationships with strategic investors early on can significantly impact the success of future transactions, including funding rounds, acquisitions, and potential exits. This article explores key insights shared by industry leaders during a panel at LSI Europe ‘23, focusing on the timing of strategic investments, the benefits and challenges of working with multiple strategics, and preparing startups for successful investor discussions.